The pharmaceutical industry in Thailand is primarily focused on producing generic drugs for the domestic market, but there is room for growth. The market value of pharmaceuticals in the country is expected to increase by 6-7% annually over the next three years, reaching around 3.2 trillion baht by 2027. This growth indicates that the industry is moving up the value chain and expanding its reach beyond local consumers.
Despite its current limitations, the Thai pharmaceutical industry has the potential to evolve and become a key player in the global market. By increasing its focus on research and development, as well as expanding its product offerings, the industry could attract international investment and partnerships. This shift towards higher value products and services can lead to greater innovation and competitiveness in the sector.
Overall, the projected growth of the pharmaceutical market in Thailand presents opportunities for the industry to expand and diversify its offerings. By capitalizing on this potential for development, the country can position itself as a leader in the region and beyond. With the right strategies and investments in place, the Thai pharmaceutical industry has the ability to transform into a key player in the global market.
Source link : Thai pharmaceutical industry moving up the value chain
